Azithromycin Protects Oligodendrocyte Progenitor Cells against Lipopolysaccharide-Activated Microglia-Induced Damage
Developmental Neuroscience · 2022 · 44 (1) · 1-12
DOI: 10.1159/000519874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neuroscience, online erschienen am 27.09.2021. Verfasst von Sumana Ramarao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Newborn Medicine, Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Oligodendrocyte Precursor Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Oligodendrocyte progenitor cells (OPC) are the primary cellular targets of brain white matter injury (WMI) in very low-birth weight (VLBW) infants. Microglia plays a significant role in inflammation-induced WMI. Our previous study showed that lipopolysaccharide (LPS)-induced OPC damage is mediated by activated microglia in vitro. We hypothesized that azithromycin (AZ) could protect OPCs against LPS-induced cytotoxicity by blocking microglial activation. Highly enriched primary rat microglia and OPCs were treated with LPS. There were 4 groups: control, LPS + Veh, AZ, and LPS + AZ. Microglia conditioned medium (MCM) was used to determine inflammatory cytokines by enzyme-linked immunosorbent assay or subsequent treatment of OPCs. We found that AZ significantly suppressed TNF-α, IL-1β, and IL-6 in LPS+Veh-treated–microglial MCM and blocked microglial nuclear factor-κB p65 nuclear translocation. AZ prevented LPS-MCM-induced OPC death and improved OPC survival as measured by activated caspase-3 immunostaining and XTT assay, respectively. AZ ameliorated LPS-MCM-induced differentiation arrest and myelin basic protein deficit in oligodendrocytes. Our data suggest that AZ is a potent inhibitor for microglia activation and may hold the therapeutic potential for WMI in VLBW infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Newborn Medicine, Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Zitieren
APA
Ramarao, S., Pang, Y., Carter, K., & Bhatt, A. (2022). Azithromycin Protects Oligodendrocyte Progenitor Cells against Lipopolysaccharide-Activated Microglia-Induced Damage. Developmental Neuroscience, 44(1), 1-12. https://doi.org/10.1159/000519874
Vancouver
Ramarao S, Pang Y, Carter K, Bhatt A. Azithromycin Protects Oligodendrocyte Progenitor Cells against Lipopolysaccharide-Activated Microglia-Induced Damage. Developmental Neuroscience. 2022;44(1):1-12. doi:10.1159/000519874
BibTeX
@article{Ramarao2022,
author = {Ramarao, Sumana and Pang, Yi and Carter, Kathleen and Bhatt, Abhay},
title = {Azithromycin Protects Oligodendrocyte Progenitor Cells against Lipopolysaccharide-Activated Microglia-Induced Damage},
journal = {Developmental Neuroscience},
year = {2022},
volume = {44},
number = {1},
pages = {1--12},
doi = {10.1159/000519874}
}
EUVIMED